Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 102.84M P/E - EPS this Y 18.00% Ern Qtrly Grth -
Income -35.32M Forward P/E -3.55 EPS next Y 22.00% 50D Avg Chg -8.00%
Sales 775.3k PEG - EPS past 5Y - 200D Avg Chg -27.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -51.00%
Recommedations 2.20 Quick Ratio 0.66 Shares Outstanding 82.07M 52W Low Chg 11.00%
Insider Own 23.92% ROA -97.27% Shares Float 62.70M Beta 1.35
Inst Own 7.97% ROE - Shares Shorted/Prior 493.62K/501.69K Price 1.35
Gross Margin 100.00% Profit Margin - Avg. Volume 148,956 Target Price 3.73
Oper. Margin -3,582.60% Earnings Date May 8 Volume 46,724 Change -1.46%
About VolitionRX Limited

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.

VolitionRX Limited News
04/08/24 VNRX: VolitionRx Reports 2023 Results; Distribution of Nu.Q Vet Test Expanding; Nu.Q Discover Growing; Two Key R&D Efforts in 2024/25: 1) Breakthrough Cancer Detection Method (Capture -PCR) 2) Nu.Q NET for Sepsis
03/27/24 VolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcript
03/25/24 VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update
03/21/24 VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update
03/20/24 Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan
03/19/24 Volition appoints Dr Andrew Retter as Chief Medical Officer
02/02/24 Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar
04:54 AM Next Big Thing: 3  Biotech Stocks to Watch for Groundbreaking Advances
01/04/24 Volition Issues Business Review 2023
12/05/23 Sidoti Events, LLC's Virtual December Small-Cap Conference
12/05/23 VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie Entreprendre
11/16/23 VolitionRx Limited (AMEX:VNRX) Q3 2023 Earnings Call Transcript
11/14/23 VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update
11/08/23 VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update
11/06/23 Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & Ireland
11/02/23 VNRX: Breakthrough Cancer Detection Method Disclosed at ESMO and in a Webinar - preliminary proof of concept work indicates simple blood test should be able to detect several types of cancer, potentially at Stages I & II
10/23/23 Volition Presents Breakthrough Liquid Biopsy Blood Test Method for Early-stage Cancer
10/19/23 Measuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic Shock
11:00 AM US Ambassador Adler visits Belgian Volition
10/16/23 Volition Presents Three Cancer Detection Abstracts at ESMO 2023
VNRX Chatroom

User Image shapenkaas Posted - 5 days ago

$VNRX interesting that the share drops further... I suppose it's due to the rush in metals and the geopolitics now. And a new capital raise, obviously, as revenues are too less, still.

User Image Bigspydee040 Posted - 5 days ago

$VNRX

User Image Bigspydee040 Posted - 5 days ago

$VNRX

User Image Bigspydee040 Posted - 5 days ago

$VNRX

User Image Bigspydee040 Posted - 5 days ago

$VNRX Following are some of findings on Facebook - Marketing going on full swing since April 2024

User Image Bigspydee040 Posted - 6 days ago

$VNRX Antech Marketing started - https://www.businesswire.com/news/home/20240410192333/en/Antech%E2%80%99s-Breakthrough-AI-powered-Radiology-and-Targeted-Cancer-Screening-Tools-Now-Available-Unleashing-New-Chapter-for-Veterinary-Diagnostics

User Image Logic102 Posted - 1 week ago

$VNRX Significantly more than a doubling of revenue in 2023 compared to 2022 is quite encouraging especially as all signs point to the same or better happening in 2024. I'm new here so not sure when the Sepsis test in humans could start getting revenue but that could make the veterinary numbers look miniscule by sometime in 2025.

User Image Logic102 Posted - 1 week ago

$VNRX Started a position today. Company seems worth more than its current Market Cap based on their current approved veterinary product alone with significant upside potential.

User Image 2021er Posted - 03/26/24

$VNRX

User Image Bigspydee040 Posted - 03/25/24

$VNRX - why is their revenue so less? Like Q4 they just made $245k and they are saying they sold 58k tests. At $7 a test they should have made at least $406k. I am so surprised.

User Image DoubleDownDave Posted - 03/25/24

$VNRX I'm impressed if that matters. You impress me you done did something. https://www.prnewswire.com/news-releases/volitionrx-limited-announces-full-fiscal-year-2023-financial-results-and-business-update-302098474.html We believe that this is a true breakthrough moment – the first reported physical isolation of a class of tumor-derived ctDNA fragments from blood. number of large-scale clinical studies due for publication later this year. 58,000 tests being sold in 2023 and has led to agreements with several new global and regional partners including, last week, with Fujifilm Vet Systems, Japan's leading veterinary diagnostic service provider.

User Image Stock_Titan Posted - 03/25/24

$VNRX VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update https://www.stocktitan.net/news/VNRX/volition-rx-limited-announces-full-fiscal-year-2023-financial-8ypf0kx4pync.html

User Image 2021er Posted - 03/23/24

$VNRX dvm360® is the leading multi-media provider of animal health care communications, education, and research for veterinary professionals. 👀https://www.dvm360.com/view/veterinary-cancer-test-now-available-in-japan

User Image Stock_Titan Posted - 03/21/24

$VNRX VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update https://www.stocktitan.net/news/VNRX/volition-rx-limited-schedules-fourth-quarter-and-full-year-2023-0cg5xlyvdzdp.html

User Image DavidStetson Posted - 03/20/24

$VNRX Thinking of jumping back in, got out the the Heska news on Jan 2. Any thoughts on the weakness? When are the year end #'s due?

User Image 2021er Posted - 03/20/24

$VNRX added

User Image Stock_Titan Posted - 03/20/24

$VNRX Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan https://www.stocktitan.net/news/VNRX/volition-and-fujifilm-vet-systems-launch-nu-q-r-vet-cancer-test-in-gzei746rh7qy.html

User Image SerendipiTea Posted - 03/19/24

$VNRX https://volition.com/dr-andrew-retter-volition-chief-medical-officer/

User Image 2021er Posted - 1 month ago

$VNRX https://fintel.io/so/us/vnrx/vanguard-group

User Image Bigspydee040 Posted - 1 month ago

$VNRX - I just got a notification from my broker that the earnings are tomorrow morning before market open ? Is it true ?

User Image 2021er Posted - 1 month ago

$VNRX https://youtu.be/L16f8KBLLqg?si=owK2Rf9zRD2KwQzQ

User Image shapenkaas Posted - 1 month ago

@everydayCPA We don't need 1 $, we need 10 $ =))

User Image everydayCPA Posted - 1 month ago

$VNRX wow right back up

User Image 2021er Posted - 1 month ago

$VNRX 25% down from recent high, up from here!🤪

Analyst Ratings
Cantor Fitzgerald Overweight Mar 27, 24
EF Hutton Buy Mar 27, 24
EF Hutton Buy Jan 2, 24
EF Hutton Buy Nov 21, 23
Cantor Fitzgerald Overweight Nov 16, 23
EF Hutton Buy Oct 30, 23
Cantor Fitzgerald Overweight Aug 16, 23
EF Hutton Buy Mar 16, 23
Benchmark Hold Feb 1, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Eight Corp Ltd 10% Owner 10% Owner Dec 15 Sell 0.75 20,000 15,000 318,419 12/20/23
Butera Salvatore Thomas CEO - Volition Veter.. CEO - Volition Veterinary Dec 18 Buy 0.83 10,000 8,300 99,350 12/19/23
Rootsaert Rodney Gerard Secretary Secretary Dec 13 Buy 0.60 10,000 6,000 78,652 12/14/23
Reynolds Cameron John President and CEO President and CEO Dec 08 Buy 0.67 10,000 6,700 1,704,518 12/11/23
Innes Guy Archibald Director Director Nov 27 Buy 0.77 20,000 15,400 627,161 11/28/23
Futcher Edward Director Director Nov 27 Buy 0.80 9,000 7,200 71,936 11/28/23
Innes Guy Archibald Director Director Nov 24 Buy 0.76 10,000 7,600 607,161 11/27/23
Innes Guy Archibald Director Director Nov 22 Buy 0.71 20,000 14,200 597,161 11/24/23
Butera Salvatore Thomas CEO - Volition Veter.. CEO - Volition Veterinary Nov 16 Buy 0.81 10,000 8,100 79,350 11/17/23
Barnes Phillip Director Director Sep 05 Buy 1.30 5,000 6,500 24,686 09/06/23
Micallef Jacob Vincent Chief Scientific Off.. Chief Scientific Officer Aug 29 Buy 1.26 20,000 25,200 55,000 08/31/23
Micallef Jacob Vincent Chief Scientific Off.. Chief Scientific Officer Aug 25 Buy 1.24 20,000 24,800 235,140 08/28/23
Kway Jasmine CEO - Singapore Voli.. CEO - Singapore Volition Aug 24 Buy 1.20 5,000 6,000 10,400 08/25/23
Futcher Edward Director Director Aug 24 Buy 1.22 5,000 6,100 62,936 08/25/23
Michel Gaetan Chief Operating Offi.. Chief Operating Officer Aug 24 Buy 1.23 5,000 6,150 212,997 08/24/23
Butera Salvatore Thomas CEO - Volition Veter.. CEO - Volition Veterinary Aug 16 Buy 1.21 8,000 9,680 69,350 08/17/23
Reynolds Cameron John President and CEO President and CEO Aug 16 Buy 1.22 10,000 12,200 1,494,518 08/16/23
Butera Salvatore Thomas CEO - Volition Veter.. CEO - Volition Veterinary Jun 02 Buy 1.59 10,000 15,900 61,350 06/06/23
Innes Guy Archibald Director Director Feb 22 Buy 1.75 234,000 409,500 154,504 02/23/23
Butera Salvatore Thomas CEO - Volition Veter.. CEO - Volition Veterinary Dec 19 Buy 2.27 5,000 11,350 51,350 12/20/22
Micallef Jacob Vincent Chief Scientific Off.. Chief Scientific Officer Dec 16 Buy 2.13 32,339 68,882 188,392 12/20/22
Faulkes Martin Charles Director Director Dec 16 Buy 2.10 55,000 115,500 1,637,068 12/19/22
Plummer Nicholas GC - Volition Diagno.. GC - Volition Diagnostics Dec 08 Buy 2.07 4,800 9,936 51,494 12/12/22
Butera Salvatore Thomas CEO - Volition Veter.. CEO - Volition Veterinary Nov 28 Buy 2.21 5,000 11,050 42,000 11/29/22
Micallef Jacob Vincent Chief Scientific Off.. Chief Scientific Officer Sep 19 Buy 1.70 13,000 22,100 35,000 09/20/22
Reynolds Cameron John President and CEO President and CEO Aug 30 Buy 1.61 3,500 5,635 1,195,518 08/30/22
Micallef Jacob Vincent Chief Scientific Off.. Chief Scientific Officer Aug 26 Buy 1.74 29,000 50,460 149,228 08/30/22
Butera Salvatore Thomas CEO - Volition Veter.. CEO - Volition Veterinary Aug 23 Buy 1.60 5,000 8,000 165,000 08/24/22
Butera Salvatore Thomas CEO - Volition Veter.. CEO - Volition Veterinary Aug 22 Buy 1.64 5,000 8,200 160,000 08/23/22
Innes Guy Archibald Director Director May 16 Buy 2.37 10,000 23,700 1,546,615 05/17/22
TERRELL JASON BRADLEY MD Chief Medical Office.. Chief Medical Officer Apr 11 Sell 2.75 10,000 27,500 27,249 04/13/22